A lthough drug-eluting stents (DES) reduce the risk of restenosis and repeated revascularization after percutaneous coronary intervention, they occasionally cause unfavorable effects, such as stent thrombosis 1 and coronary hyperconstricting responses, not only to acetylcholine 2 but also to exercise.
A lthough drug-eluting stents (DES) reduce the risk of restenosis and repeated revascularization after percutaneous coronary intervention, they occasionally cause unfavorable effects, such as stent thrombosis 1 and coronary hyperconstricting responses, not only to acetylcholine 2 but also to exercise. 3 We and others have recently demonstrated high prevalence of coronary vasomotor abnormalities after percutaneous coronary intervention (≈50%) in both white and Japanese patients. 4, 5 Furthermore, recent clinical trial showed that new or worsening angina was also documented in 30% of patients who underwent successful percutaneous coronary intervention with the most promising DES, everolimus-eluting stents. 6 Thus, DES-induced coronary hyperconstricting responses are an emerging worldwide concern after stent implantation. [4] [5] [6] We have previously demonstrated that activation of Rhokinase pathway-a central mechanism of coronary spasm-in vascular smooth muscle cells plays key roles in the pathogenesis of coronary spasm 7, 8 and DES-induced coronary hyperconstricting responses in animals 9 and humans. 2 Importantly, coronary adventitial inflammation, including infiltration of macrophages, and interleukin-1β-positive cells are involved in the pathogenesis of coronary spasm. [10] [11] [12] We also have demonstrated that formation of coronary adventitial vasa vasorum (VV), which are nutrient blood vessels of the vascular wall, is enhanced in the coronary adventitia of patients with vasospastic angina. 13 We also have recently reported that enhanced VV formation in the coronary adventitia after DES implantation is closely associated with coronary hyperconstricting responses. 12 The adventitia harbors a variety of components that potently modulate vascular tone, including not only inflammatory cells and VV but also sympathetic nerve fibers (SNF). Circadian variation and changes in autonomic nervous system activity are involved in angina attacks in patients with vasospastic angina. 14, 15 Indeed, surgical sympathectomy has been reported to be effective for the treatment of refractory angina. 16 However, the procedure is invasive in nature and, thus, cannot be performed repeatedly. Currently, catheter-based renal denervation (RDN) has been developed to reduce sympathetic nerve activity, 17, 18 which significantly reduced blood pressure (BP) in patients with resistant hypertension. [19] [20] [21] Furthermore, RDN is reported to have cardioprotective effects on cardiac myocytes to attenuate cell death and protect against ischemic injury in an animal model. 22 It is, thus, conceivable that RDN could be a therapeutic option for impaired coronary vasomotion after DES implantation through inhibition of the adventitial SNF.
In the present study, we, thus, examined (1) whether DESinduced coronary hyperconstricting responses are associated with enhanced coronary adventitial SNF formation, and if so, (2) whether RDN affects sympathetic autonomic nervous system through the kidney-brain-heart axis, and (3) whether RDN suppresses coronary hyperconstricting responses after DES implantation in pigs in vivo.
Materials and Methods
We conducted 2 experimental protocols. In protocol 1 ( Figure 1A) , we examined whether DES-induced coronary hyperconstricting responses are associated with enhanced coronary adventitial SNF formation. In protocol 2 ( Figure 1B) , we examined whether RDN affects sympathetic autonomic nervous system and whether RDN suppresses coronary hyperconstricting responses after DES implantation in pigs in vivo. Detailed Methods are available in the online-only Data Supplement.
Results

Protocol 1: DES Enhances Coronary Adventitial SNF
In protocol 1 ( Figure 1A) , at 1 month after stent implantation, no significant in-stent restenosis was noted at the stent implantation sites (Figure 2A) . In protocol 1, coronary vasoconstricting responses and histomorphometrical values at the proximal and distal edges in a pig were treated as individual factors ( Figure I in the online-only Data Supplement). Coronary vasoconstricting responses to intracoronary serotonin were enhanced at the DES edges compared with the control sites ( Figure 2B ), and all of them were abolished by pretreatment with hydroxyfasudil ( Figure 2C ). Quantitative coronary angiography analysis showed that serotonininduced coronary vasoconstriction was significantly enhanced at the DES edges compared with the control sites (control, 12.8±4.6%; DES, 47.2±3.6%; P<0.01; Figure 2D ). Masson trichrome staining showed that the coronary adventitial nerve fibers were noted more prominent at the DES edges, as compared with the control sites ( Figure 2E and 2J) . Indeed, tyrosine hydroxylase (TH) staining showed that the number of TH-positive SNF in the adventitia was significantly increased at the DES edges compared with the control sites (P<0.01; Figure 2F , 2K, and 2O). Similarly, the number of vWF-positive Figure 1 . A, Protocol 1: an everolimus-eluting stent (EES) was randomly implanted into the left anterior descending coronary artery (LAD) or the left circumflex coronary artery (LCX) in 6 pigs. At 1 mo after stent implantation, all animals underwent follow-up coronary angiography followed by histological analysis. B, Protocol 2: EES were implanted into both the LAD and the LCX in 18 pigs. Subsequently, pigs were randomly assigned to either bilateral renal denervation (RDN) or sham group and underwent each procedure (N=9 each). At 1 mo after the procedure, all animals underwent microneurography and follow-up coronary angiography, followed by histological analysis. Blood pressure and blood analysis were performed before the stent implantation and at 1 mo during follow-up angiography. microvessels in the adventitia was significantly increased at the DES edges compared with the control sites (P<0.01; Figure 2G , 2L, and 2P). Immunoreactivities of both neuropeptide Y (NPY) and nerve growth factor (NGF) predominantly expressed in the adventitial SNF were enhanced at the DES edges compared with the control sites ( Figure 2H , 2I, 2M, and 2N). Furthermore, semiquantitative analysis for the extents of NPY and NGF expression in the adventitial SNF showed that both expressions were significantly increased at the DES edges compared with the control sites (all P<0.01; Figure 2Q and 2R). Of note, immunofluorescence staining showed that coronary adventitial SNF and VV were closely observed as if they form like a network, and there was a significant positive correlation between the adventitial SNF and VV densities at the stent edges with vasoconstriction sites (P<0.01; Figure 2S and 2T). Moreover, there was a significant positive correlation between the adventitial SNF density at the vasoconstriction sites and the extent of serotonin-induced coronary vasoconstricting responses (P<0.01; Figure 2U ).
Protocol 2: RDN Inhibits DES-Induced Coronary Hyperconstricting Responses and Enhanced Coronary Adventitial SNF
RDN Procedure
In the RDN procedure, the power output was maintained at 9-10 W during the procedure ( Figure IIA in the online-only Data Supplement). The impedance significantly decreased after RDN compared with that before the procedure (pre, 162±1Ω; post, 152±1Ω; n=126; P<0.01; Figure IIB in the online-only Data Supplement). The localized temperature was maintained under 50°C without overheating ( Figure IIC in the online-only Data Supplement). Immediately after the RDN procedure, renal artery angiography showed no evidence of renal artery thrombus, dissection, or perforation ( Figure 3A and 3B). The mean number of notch, which indicated a biological effect of energy delivery on the artery defined as a visible depression in vessel wall at the site of ablation on fluoroscopic image, 23 was 4.5±1.5 per renal artery in the RDN group (n=18). At 1 month after the procedure, there was no evidence of renal artery stenosis, thrombus, dissection, or perforation ( Figure 3C ).
Histomorphometry of the Renal Artery
At 1 month after the RDN procedure, the renal arteries showed medial fibrosis, suggesting appropriate healing. There was no medial thinning, aneurysm, rupture, or thrombus formation ( Figure 3D and 3G). As previously reported, 18 the perivascular nerves showed degenerative change in the RDN group ( Figure 3E and 3H) . TH staining-a marker of sympathetic nerve viability-showed that >90% renal nerves were damaged in the RDN group (grades 3 and 4; 94%), whereas almost all renal nerves were intact in the sham group (grade 0-2; 99%; Figure 3F , 3I, and 3K). 1,3,5-triphenyl tetrazolium chloride staining at 2 hours after the procedure clearly showed that RDN caused severe damage on the endothelium of bilateral renal arteries ( Figure 3J ). Figure 4D ).
In Vitro Autoradiography of the Brain Stem
Effects of RDN on Muscle Sympathetic Nerve Activity
At 1 month after RDN or sham procedure, filtered microneurogram and its integrated microneurogram (an established and reliable parameter reflecting sympathetic nerve activity) were recorded ( Figure 4E through 4G) . 24, 25 Integrated microneurogram showed that muscle sympathetic nerve activity was significantly attenuated in the RDN group compared with the sham group (sham, 54±4 bursts/min; RDN, 39±3 bursts/min; P<0.05).
Effects of RDN on Arterial BP and Heart Rate
At baseline, systolic (SBP), diastolic, and mean BP and HR were all comparable between the sham and the RDN groups (Table 1) . SBP increased from baseline to 1 month after the procedure in the sham group (before the procedure, 95±4 mm Hg; 1 month after the procedure, 115±5 mm Hg; change over time, 19±4 mm Hg P<0.01 [by using pared, 2-sided Student t test]). In contrast, in the RDN group, there were no significant changes (before the procedure, 97±4 mm Hg; 1 month after the procedure, 102±3 mm Hg; change over time, 5±6 mm Hg; P=0.43). In contrast, although diastolic and mean BP also increased in both groups, there were no significant differences in the extent of the BP increase between the 2 groups. Furthermore, there were no significant differences in the HR changes between the 2 groups.
Effects of RDN on Blood Analysis
At baseline, serum levels of electrolytes, renal function, and renin-angiotensin-aldosterone system were all comparable between the sham and the RDN groups (Table 2) . Serum levels of potassium, chloride, creatinine, and aldosterone remained unchanged from baseline to 1 month after the procedure between the 2 groups. However, the extent of the increase in plasma renin activity was significantly lower in the RDN group compared with the sham group (P<0.05). In addition, the extent of increase in sodium and urea nitrogen were also significantly lower in the RDN group compared with the sham group (all P<0.05).
Stent Implantation
There were no significant differences in the procedural parameters for stent implantation between the sham and the RDN groups, including target vessel diameter, stent diameter, or overstretch ratio (Table 3) .
Effects of RDN on Coronary Vasomotion
After Stent Implantation At 1 month after stent implantation, no in-stent restenosis was noted ( Figure 5A and 5D) . Notably, coronary vasoconstricting responses to intracoronary serotonin were attenuated at the proximal and distal stent edges in the RDN group compared with the sham group ( Figure 5B and 5E ), all of which were abolished by pretreatment with hydroxyfasudil ( Figure 5C and 5F). Quantitative coronary angiography analysis demonstrated that serotonin-induced coronary vasoconstriction was significantly attenuated in the RDN group compared with the sham group (sham, 30.2±3.5%; RDN, 14.4±3.3%; P<0.01; Figure 5G ). In contrast, endothelium-dependent and independent coronary vasodilating responses to nitroglycerin and bradykinin were all comparable between the 2 groups, regardless of the presence or absence of N G -monomethyl-L-arginine (Table 4) .
Histomorphometry of the Stent Edges
Histomorphometric parameters at the stent edges were all comparable between the sham and the RDN groups (Table 5) .
Effects of RDN on Coronary Adventitial SNF and VV Formation at the Stent Edges
At the stent edges, Masson trichrome stainings showed that the number of nerve fibers in the coronary adventitia was smaller in the RDN group, as compared with the sham group ( Figure 6A and 6F) . Indeed, TH staining showed that the number of TH-positive SNF in the adventitia was significantly reduced in the RDN group, as compared with the sham group The number N represents that of pigs. Results are expressed as mean±SEM. Δ indicates the difference between before and 1 mo after the procedure. BP indicates blood pressure; RDN, renal denervation; and SBP, systolic blood pressure.
(P<0.01; Figure 6B , 6G, and 6K). Similarly, the number of vWF-positive VV in the adventitia was significantly reduced in the RDN group compared with the sham group (P<0.01; Figure 6C , 6H, and 6L). Furthermore, semiquantitative analysis for the extents of NPY and NGF expression in the adventitial SNF showed that both expressions were significantly decreased in the RDN group compared with the sham group (all P<0.01; Figure 6D , 6E, 6I, 6J, 6M, and 6N). Importantly, there was a significant positive correlation between the adventitial SNF and VV densities at the stent edge vasoconstriction sites (P<0.01; Figure 6O ). 
Effects of RDN on Adventitial Inflammatory Changes at the Stent Edges
Effects of RDN on Rho-Kinase Activity at the Stent Edges
Immunoreactivities for Rho-associated coiled coil containing protein kinase 1/2 and phosphorylated myosin phosphatase target subunit-1 (a marker of Rho-kinase activity) 26 were predominantly noted in the medial vascular smooth muscle cells. In the semiquantitative analysis, the extent of Rho-associated coiled coil containing protein kinase 1/2 expressions and Rhokinase activation (phosphorylated myosin phosphatase target subunit-1) at the stent edges were significantly lower in the RDN group compared with the sham group (all P<0.05; Figure IIIM through IIIO, IIIQ through IIIS, and IIIT through IIIV in the online-only Data Supplement).
Discussion
The major findings of the present study were that (1) enhanced SNF and VV formation were noted at the edges of DES implantation sites with enhanced coronary vasoconstricting responses, (2) NTS regions in the central nervous system were influenced by the RDN procedure with resultant decrease in BP and reduced activity of plasma renin and muscle sympathetic nerves, (3) RDN attenuated coronary vasomotion abnormalities after DES implantation in pigs in vivo, (4) RDN also attenuated SNF, VV, and inflammation in the coronary adventitia and Rho-kinase activation after DES implantation, and (5) there were significant correlations between morphological changes (eg, SNF, VV, and inflammatory cell infiltration) and functional changes of the coronary artery (eg, hyperconstricting responses).
Coronary Adventitial SNF and DES-Induced Coronary Hyperconstricting Responses
The present study demonstrates for the first time in pigs that coronary adventitial SNF were enhanced associated with VV growth at the stent implantation sites. Of note, immunofluorescence staining revealed that coronary adventitial SNF and VV are closely present like a tangle. In addition, enhanced coronary adventitial SNF formation was positively correlated with the extent of serotonin-induced coronary vasoconstriction, suggesting that sympathetic hyperactivity is involved in the pathogenesis of The number N represents that of pigs. Results are expressed as mean±SEM. Δ indicates the difference between before and 1 mo after the procedure. ALD indicates plasma levels of aldosterone; BUN, blood urea nitrogen; Cl, plasma chloride level; K, potassium; Na, sodium; PRA, plasma renin activity; RDN, renal denervation; and Scr, serum creatinine. Results are expressed as mean±SEM. Stent diameter was calculated by averaging the diameters at the proximal edge, mid portion, and distal edge of the stented coronary artery. Overstretch ratio was calculated as the stent diameter divided by target vessel diameter. Distal overstretch ratio was calculated as the distal stent diameter divided by distal reference vessel diameter. LAD indicates left anterior descending coronary artery; LCX, left circumflex coronary arteries; and RDN, renal denervation.
coronary hyperconstricting responses after DES implantation. Furthermore, we showed that the expressions of the neuromodulators, NPY (an angiogenic factor), and NGF (a neurogenic factor) in the coronary adventitial SNFs were enhanced at the DES edges, suggesting possible interactions between VV and SNF. Indeed, recent studies suggest that peripheral nervous system directly influences blood vessel pattern resulting in nerve-artery alignment. 27, 28 Thus, it is possible that augmented SNF is involved in the VV formation with resultant coronary hyperconstricting responses at the DES-implanted site. These results suggest that modulation of autonomic nerve activity with catheter-based RDN has potential therapeutic effects to improve coronary vasomotion abnormalities through inhibition of VV formation and inflammatory cell recruitment.
Inhibitory Effects of RDN on Sympathetic Nervous System
We first validated the damage by RDN in bilateral renal arteries. Renal artery angiography showed several notches immediately after RDN, which indicated a biological effect of energy delivery on the artery. 23 Sub analysis of the SYMPLICITY-HTN-3 trial, a trial of 535 patients with resistant hypertension randomized to RDN or a sham control procedure, demonstrated that patients who received >14 ablation attempts had significantly greater reduction in home and office SBP, whereas those who received <9 ablation attempts had no reduction in BP. 29 In line with this finding, we performed frequent ablation attempts (14× per pig) with monitoring power output, localized impedance, and localized temperature. We confirmed successful reduction in localized impedance after RDN without overheating and no late stenosis at the ablation sites. Furthermore, we histologically confirmed that RDN caused marked damages of SNF surrounding the renal arteries.
We then examined the effects of RDN on brain function by using in vitro autoradiography. In the present study, we were able to demonstrate for the first time the brain images showing functional alterations in response to the RDN procedure. Strikingly, the [ 3 H]rauwolscine binding to α 2 -adrenergic receptor in the NTS regions was significantly upregulated in the RDN group. NTS is the area of the brain stem that plays a key role in the regulation and integration of autonomic nerves activities. 30 It is known that renal afferent input interacts with cardiovascular afferent input at neurons in the NTS. 31 The NTS also receives baroreceptor afferents and a dense noradrenergic input. 32 Notably, hypertensive animals show downregulation of the [ 3 H]rauwolscine binding to α 2 -adrenergic receptor in the NTS regions. 30 In contrast, stimulation of α 2 receptor within the NTS promotes a strong hypotensive response. 33, 34 Thus, RDN may cause (1) upregulation of α 2 receptor in NTS, (2) downregulation of sympathetic nerve activity, and subsequently (3) suppression of DES-induced coronary hyperconstricting responses and attenuation of SNF in coronary adventitia. However, detailed mechanisms remain to be elucidated in future studies.
We also examined the effects of RDN on systemic autonomic nerve activity. RDN significantly decreased levels of plasma renin activity indicate possible suppression of the renin-angiotensin-aldosterone system by RDN. Furthermore, a reduction in muscle sympathetic nerve activity after RDN procedure, as assessed in the femoral nerve using microneurography, highlighted the possibility that inhibition of afferent bilateral renal nerve activity could contribute to a decrease in central sympathetic drive through the NTS pathway.
Effects of RDN on BP and HR
In porcine models with hypertension, inhibitory effect of RDN on SBP was noted. 35, 36 In the present study with normotensive pigs, RDN also significantly decreased SBP compared with the sham group at 1 month after the procedure, although the extent of SBP changes during 1 month remained unchanged in the RDN group compared with the sham group. In humans, procedural performance, such as the frequency of ablation, might influence the degree of SBP reduction after RDN. 29 In the present study, RDN did not significantly affect HR. In patients with resistant hypertension who underwent >14 ablations, RDN caused significant reduction in HR (−4.5 bpm) at 6 months after the procedure. 29 However, it has been reported that RDN did not significantly affect HR in porcine models. 35, 36 Thus, the mechanisms and discrepancy of the effects of RDN on BP and HR between pigs and humans remain to be examined in future studies.
Effects of RDN on Coronary Adventitia and Vasomotion
It is important to demonstrate the key roles of the adventitia for the assessment of the effect of RDN on coronary vasomotion abnormalities. Signals originating from the adventitia play essential roles in the regulation of physiology and vascular disease, such as coronary artery spasm. 10 The adventitia harbors a variety of components that potently modulate vascular tone, including inflammatory cells, VV, and importantly SNF. 37 Coronary spasm can be induced by stimuli, such as cold pressor test, that increases sympathetic outflow. 38 Circadian variation of autonomic nervous system activity in angina attacks in patients with vasospastic angina also suggests an involvement of the coronary adventitial SNF. 15 Thus, the present findings suggest that SNF in the adventitia is a potential therapeutic target for coronary vasomotion abnormalities.
VV could be a conduit of inflammatory cells to the adventitia. 37 We also have recently demonstrated that enhanced VV formation in the coronary adventitia is associated with DESinduced coronary hyperconstricting responses in pigs in vivo 12 and coronary spasm in humans. 13 In the present study, it is considered that RDN reduced SNF and VV formation after DES implantation, which could inhibit the recruitment of inflammatory cells and advanced inflammation. The adventitia is also in contact with and is completely surrounded by the media that is predominantly composed of vascular smooth muscle cells that regulate vasomotor function. Indeed, we demonstrated that Rho-kinase activation of vascular smooth muscle cells in response to the adventitial inflammation plays important roles in the pathogenesis of coronary spasm in animals. 11 These findings provide an important insight into the adventitia as a potential therapeutic target for coronary vasomotion abnormalities. The The number N represents that of pigs. Results are expressed as mean±SEM. The adventitial area was calculated by the following formula: area outside the EEL within a distance of the thickness of neointima plus media−EEL area. EEL indicates external elastic lamina; and RDN, renal denervation.
However, from a clinical point of view, it is difficult to deliver pharmacological agents or genes into the coronary adventitia in humans. Based on the present findings, it is conceivable that RDN could be used as a treatment option to modify the adventitial SNF associated with adjacent VV and inflammatory cells and resultant consequences of the disorder.
Translational Perspective
Surgical sympathectomy has been reported to be effective for the treatment of refractory angina, 16 although the procedure is invasive in nature and, thus, cannot be performed repeatedly. Currently, intractable vasospastic angina and unremitting angina even after successful percutaneous coronary intervention are also emerging therapeutic targets. [4] [5] [6] In the present study, we were able to demonstrate that RDN ameliorates coronary hyperconstricting responses after DES implantation in pigs in vivo through the possible kidney-brain-heart axis (Graphic Abstract). Thus, RDN could be used as a treatment option to modify the adventitial SNF associated with adjacent VV and inflammatory cells and resultant vasospastic disorder.
Study Limitations
Several limitations should be mentioned for the present study. First, time course and interactions between SNF and VV formation after DES implantation and RDN procedure remain to be elucidated. Recent studies suggest that some neurotrophic factors, including NPY and NGF, have angiogenic effects and stimulate regeneration and maturation of perivascular nerves. 27, 39 Second, in the present study, we only examined the effects of RDN procedure in a prevention protocol. Thus, it remains to be examined whether RDN, as a secondary prevention, improves established coronary vasomotion abnormalities after DES implantation. Third, we used serotonin to examine coronary vasoconstricting responses, as previously described. 9, 12, 26 Although acetylcholine is most frequently used to provoke coronary artery spasm in the clinical setting, serotonin may better mimic spontaneous coronary spasm in humans than acetylcholine. 40 Fourth, we used normal pig with neither impaired endothelial function nor abundant atherosclerotic burden. Thus, caution should be paid when applying the present results to humans. 
Conclusions
The present study demonstrates that bilateral RDN ameliorates coronary hyperconstricting responses after DES implantation in pigs in vivo through suppression of the kidney-brain-heart axis, including suppressions of coronary adventitial SNF, VV formation, inflammation, and Rho-kinase activation, suggesting that RDN is a novel therapeutic option for refractory angina.
